Literature DB >> 9202714

CHO transfectants produce large amounts of recombinant protein in suspension culture.

C Schütt1, B Fürll, F Stelter, R S Jack, S Witt.   

Abstract

Chinese hamster ovary (CHO) cells transfected with various genes are widely used as adherent cell monolayers to produce recombinant proteins. In this report we present a new culture technique for CHO cells transfected with the vector pPOL-DHFR-CD14 using a minifermenter (miniPERM, Heraeus) for the production of recombinant human endotoxin receptor CD14 (rCD14). The transfectants were cultured for 12-17 days under serum-free conditions and formed spheroids. From this system we harvested supernatants containing up to 3.1 mg/ml recombinant CD14 (rCD14). This represents a 200-fold increase of rCD14 yield compared to conventional adherent CHO cell culture.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202714     DOI: 10.1016/s0022-1759(97)00027-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

Review 1.  Microalgae as bioreactors.

Authors:  Tara L Walker; Saul Purton; Douglas K Becker; Chris Collet
Journal:  Plant Cell Rep       Date:  2005-08-31       Impact factor: 4.570

2.  Human CD14 expressed in seeds of transgenic tobacco displays similar proteolytic resistance and bioactivity with its mammalian-produced counterpart.

Authors:  David R Blais; Illimar Altosaar
Journal:  Transgenic Res       Date:  2006-04       Impact factor: 2.788

3.  Elevated levels of lipopolysaccharide-binding protein and soluble CD14 in plasma in neonatal early-onset sepsis.

Authors:  Reinhard Berner; Birgitt Fürll; Felix Stelter; Jana Dröse; Hans-Peter Müller; Christine Schütt
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

4.  Production of anti TNF-α antibodies in eukaryotic cells using different combinations of vectors carrying heavy and light chains.

Authors:  Dmitriy Balabashin; Elena Kovalenko; Viktoria Toporova; Teimur Aliev; Anna Panina; Elena Svirshchevskaya; Dmitry Dolgikh; Mikhail Kirpichnikov
Journal:  Cytotechnology       Date:  2014-06-18       Impact factor: 2.058

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.